Yesterday, a broad range of regulators, CEOs, VCs, stakeholders, industry representatives and journalists met to share their perspectives on the role of biotechnology in contributing to the creation of Europe’s Innovation Union.
Today’s unveiling by Commissioner Geoghegan-Quinn and Vice President Tajani, of the Commission’s plans to turn Europe into an ‘Innovation Union’ by 2020 is welcomed by EuropaBio’s members from across the healthcare, agricultural and industrial biotechnology sectors.
Yesterday, a new High-Level Group on Key Enabling Technologies (KET) was officially inaugurated by the European Commission’s Vice-President Antonio Tajani, Vice-President Neelie Kroes and Commissioner Maire Geoghegan-Quinn.
Today, on the occasion of the Association’s Annual General Meeting, EuropaBio is proud to launch a new high-level brief entitled “Europe 2020 and Biotechnology: Creating a Competitive, Connected and Greener Economy.”
Biotech companies worldwide reported a profit in 2009 for the first time since 1985 as revenues increased and spending on R&D was cut.
A report published yesterday by Ernst and Young Global Ltdrevealed that the industry had made a profit of $3.7 billion, compared with a loss of $1.8 billion in 2008 in the U.S, Europe, Canada and Australia.